| PDF (200kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-268227
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.26822
Zusammenfassung
Clarithromycin is a new macrolide that has a longer half-life than erythromycin and is claimed to reach higher tissue concentrations. We aimed to investigate whether, following oral administration, the drug and its 14-hydroxy metabolite reach levels in lung tissue that are likely to be clinically effective against common respiratory pathogens. Ten patients undergoing diagnostic bronchoscopy ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags